Anavex Life Sciences Corporation (AVXL) concluded trading on Thursday at a closing price of $6.62, with 5.84 million shares of worth about $38.67 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 76.06% during that period and on October 31, 2024 the price saw a gain of about 15.94%. Currently the company’s common shares owned by public are about 84.80M shares, out of which, 82.12M shares are available for trading.
Stock saw a price change of 24.20% in past 5 days and over the past one month there was a price change of 17.06%. Year-to-date (YTD), AVXL shares are showing a performance of -28.89% which increased to 18.64% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $3.25 but also hit the highest price of $10.45 during that period. The average intraday trading volume for Anavex Life Sciences Corporation shares is 693.23K. The stock is currently trading 20.17% above its 20-day simple moving average (SMA20), while that difference is up 18.71% for SMA50 and it goes to 29.03% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Anavex Life Sciences Corporation (NASDAQ: AVXL) currently have 84.80M outstanding shares and institutions hold larger chunk of about 31.73% of that.
The stock has a current market capitalization of $561.34M and its 3Y-monthly beta is at 0.62. It has posted earnings per share of -$0.50 in the same period. It has Quick Ratio of 12.04 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for AVXL, volatility over the week remained 9.83% while standing at 5.93% over the month.
Stock’s fiscal year EPS is expected to rise by 9.44% while it is estimated to decrease by -15.34% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Cantor Fitzgerald on December 06, 2022 offering a Neutral rating for the stock and assigned a target price range of between $16 and $11 to it. Coverage by Berenberg stated Anavex Life Sciences Corporation (AVXL) stock as a Buy in their note to investors on June 23, 2022, suggesting a price target of $40 for the stock. On September 23, 2021, BTIG Research Initiated their recommendations, while on December 16, 2020, H.C. Wainwright Reiterated their ratings for the stock with a price target of $17. Stock get a Buy rating from Ladenburg Thalmann on September 28, 2020.
